Jiuzhitang Co., Ltd.

000989

CNE000001394

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 14/07/2024 BST			5-day change	1st Jan Change
6.49 ^CNY	-1.67%		+1.56%	-35.87%

07-01	Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	CI
05-20	Jiuzhitang Co., Ltd. Approves Final Cash Dividend for the Year 2023	CI

Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.

July 01, 2024 at 05:00 pm

From April 1, 2024 to June 30, 2024, the company has repurchased 9,410,000 shares, representing 1.1% for CNY 74.32 million. With this, the company has completed the repurchase of 9,410,000 shares, representing 1.1% for CNY 74.32 million under the buyback announced on March 19, 2024.

Latest news about Jiuzhitang Co., Ltd.

Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	07-01	CI
Jiuzhitang Co., Ltd. Approves Final Cash Dividend for the Year 2023	05-20	CI
Jiuzhitang Co., Ltd.(XSEC:000989) dropped from S&P Global BMI Index	05-07	CI
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	04-24	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Tranche Update on Jiuzhitang Co., Ltd.'s Equity Buyback Plan announced on March 19, 2024.	04-02	CI
Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	03-18	CI
Jiuzhitang Co., Ltd. authorizes a Buyback Plan.	03-17	CI
Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%	11-02	MT
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	07/08/23	CI
Jiuzhitang Unit to Hold Clinical Trial Into Stem Cell Treatment	12/06/23	MT
Jiuzhitang Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	30/05/23	CI
Jiuzhitang Co., Ltd. Approves Cash Dividend for the Year 2022	25/05/23	CI
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend for 2022	04/05/23	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Jiuzhitang Co., Ltd. Appoints Bo Jinfeng as Non-Independent Director	11/01/23	CI
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Jiuzhitang Cleared to Launch Clinical Trial of Deep Vein Thrombosis Drug	22/09/22	MT
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22	CI
Jiuzhitang Co., Ltd. Appoints Wang Yonghui as a Non-Independent Director	17/08/22	CI
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021 Payable on 01 June 2022	26/05/22	CI
Yifeng Pharmacy Chain Co., Ltd. completed the acquisition of a 51% stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd..	25/05/22	CI
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021	23/05/22	CI
Jiuzhitang Co., Ltd. Proposes Profit Distribution for 2021	25/04/22	CI

Chart Jiuzhitang Co., Ltd.

Duration

Period

More charts

Company Profile

JIUZHITANG CO.,Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese patent drugs. The Company provides products through three categories, which include over the counter (OTC) drugs, prescription drugs and comprehensive health series. The Companyâs main products include Liuwei Dihuang pills, Xiaoyao pills, Shuxuetong injection, compound Jiangzhi tablets and E-Jiao series health products, among others. The Company distributes its products in domestic market.

Sector

Pharmaceuticals

Calendar

30/07/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
JIUZHITANG CO., LTD.	-35.87%	766M
DONG-E-E-JIAO CO.,LTD.	+13.97%	4.99B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-32.08%	3.61B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-1.63%	3.1B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.62%	2.64B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.82%	2.32B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+38.87%	1.85B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+38.84%	1.43B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.47%	1.39B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.37B